“…Tumor antigens and ectopic hormones, such as CEA, AFP, NSE, CA50, CA724, CA125, etc., are currently the most often utilized tumor biomarkers in clinic [27][28][29][30][31]. CEA is a broad-spectrum tumor marker that can be used to assess e cacy, monitor disease progression, and predict prognosis in lung cancer, colorectal cancer, breast cancer, and other cancers [32][33][34].…”